[1]彭动斌,唐雪峰,高自然,等.下调Notch3表达对骨肉瘤细胞生物学特性的影响[J].第三军医大学学报,2018,40(07):551-556.
 PENG Dongbin,TANG Xuefeng,GAO Ziran,et al.Effect of down-regulating Notch3 expression on biological characteristics of osteosarcoma cells[J].J Third Mil Med Univ,2018,40(07):551-556.
点击复制

下调Notch3表达对骨肉瘤细胞生物学特性的影响(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第07期
页码:
551-556
栏目:
基础医学
出版日期:
2018-04-15

文章信息/Info

Title:
Effect of down-regulating Notch3 expression on biological characteristics of osteosarcoma cells
作者:
彭动斌唐雪峰高自然吕杨帆郭乔楠
陆军军医大学(第三军医大学)第二附属医院病理科
Author(s):
PENG Dongbin TANG Xuefeng GAO Ziran LYU Yangfan GUO Qiaonan

Department of Pathology, Seconcd Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, China

关键词:
Notch3骨肉瘤增殖凋亡侵袭迁移
Keywords:
Notch3 osteosarcoma proliferation apoptosis invasion migration
分类号:
R394.2;R730.23;R738.1
文献标志码:
A
摘要:

目的    观察Notch3在骨肉瘤细胞中的表达及下调Notch3表达后对骨肉瘤细胞增殖、凋亡及侵袭迁移的影响,探讨Notch3在骨肉瘤细胞生物学功能中的作用。方法    体外培养人骨肉瘤细胞MG63、Saos2、U2OS,采用Real-time PCR和Western blot检测3种骨肉瘤细胞系中Notch3的mRNA和蛋白表达水平;利用siRNA敲低Notch3在骨肉瘤U2OS细胞中的表达,并将细胞分为siNotch3组和阴性对照组,检测下调Notch3的表达后骨肉瘤细胞增殖、凋亡及侵袭、迁移等生物学特性的变化。结果    Notch3在骨肉瘤细胞MG63、Saos2、U2OS中均呈阳性表达,并且在低级别骨肉瘤细胞系MG63中的表达明显低于高级别细胞系Saos2和U2OS(P<0.05),下调Notch3的U2OS细胞(siNotch3组)增殖、侵袭、迁移能力较阴性对照组减弱,凋亡率增加,差异均有统计学意义(P<0.05)。结论    在骨肉瘤细胞U2OS中下调Notch3的表达可明显抑制细胞的增殖、侵袭、迁移能力,促进凋亡。Notch3可能是Notch通路在骨肉瘤中的关键受体之一,并参与了骨肉瘤的发生、发展。

Abstract:

Objective    To explore the expression of Notch3 in human of osteosarcoma cells and determine the effect of its down-regulation on the proliferation, apoptosis, invasion and migration, and to investigate its role in the biological function of the cells. Methods    Realtime PCR and Western blotting were used to examine the expression of Notch3 at mRNA and protein levels in osteosarcoma cell lines. siRNA was used to knockdown the expression of Notch3 in U2OS cells. Then the proliferation, apoptosis and metastasis of the cells after transfection were detected for the effects of Notch3 downregulation. ResultsNotch3 was highly expressed in human osteosarcoma cell lines MG63, Saos2 and U2OS, but its level was significantly lower in MG63 cells  derived from lowgrade osteosarcoma than those in Saos2 and U2OS cells derived from highgrade osteosarcoma (P<0.05). When compared with untreated cells (Control), downregulation of Notch3 in U2OS cells markedly repressed cell proliferation, decreased invasion and migration (P<0.05). but enhanced apoptosis (P<0.05). ConclusionDownregulation of Notch3 reduces the proliferation, invasion, migration, but increases the apoptosis in osteosarcoma cells. Notch3 may be a key receptor of Notch pathway involving in the occurrence and development of osteosarcoma.

参考文献/References:

[1]MIRABELLO L, TROISI R J, SAVAGE S A.Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program[J]. Cancer, 2009,115(7): 1531-1543. DOI: 10.1002/cncr.24121.
[2]SICLARI V A, QIN L.Targeting the osteosarcoma cancer stem cell[J]. J Orthop Surg Res,2010,5:78. DOI:10.1186/1749-799X-5-78.
[3]LONGHI A, ERRANI C, DE PAOLIS M, et al. Primary bone osteosarcoma in the pediatric age: state of the art[J]. Cancer Treat Rev, 2006, 32(6): 423-436. DOI:10.1016/j.ctrv.2006.05.005.
[4]RANGANATHAN P, WEAVER K L,CAPOBIANCO A J.Notch signalling in solid tumours: a little bit of everything but not all the time[J]. Nat Rev Cancer, 2011,11(5): 338-351. DOI: 10.1038/nrc3035.
[5]LI C J,LIU X Z, ZHANG L,et al. Advances in bone-targeted drug delivery systems for neoadjuvant chemotherapy for  osteosarcoma[J]. Orthop Surg, 2016, 8(2): 105-110.DOI: 10.1111/os.12238.
[6]YU L, FAN Z,FANG S,et al.Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling[J]. Oncotarget, 2016, 7(22): 33055-33068.DOI:10.18632/oncotarget.8849.
[7]BRZOZOWAZASADA M, PIECUCH A, DITTFELD A, et al. Notch signalling pathway as an oncogenic factor involved in cancer development[J]. Contemp Oncol (Pozn), 2016,20(4):267-272.DOI: 10.5114/wo.2016.61845.
[8]BRZOZOWA M, MIELAN'CZYK L, MICHALSKI M, et al.Role of Notch signaling pathway in gastric cancer pathogenesis[J]. Contemp Oncol (Pozn), 2013,17(1):1-5. DOI:10.5114/wo.2013.33765.
[9]YUAN X, ZHANG M, WU H, et al. Expression of Notch1 correlates with breast cancer progression and prognosis[J]. PLoS ONE, 2015,10(6):e0131689. DOI:10.1371/journal. pone.0131689.
[10]ZHOU L, ZHANG N, SONG W, et al. The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma[J]. PLoS ONE,2013,8(2):e57382. DOI: 10.1371/journal.pone.0057382.
[11]OSANYINGBEMIOBIDI J, DOBROMILSKAYA I, ILLEI P B, et al. Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo[J]. Mol Cancer Res, 2011,9(12):1746-1754. DOI: 10.1158/1541-7786.MCR-11-0286.
[12]ENGIN F, BERTIN T, MA O, et al. Notch signaling contributes to the pathogenesis of human osteosarcomas[J]. Hum Mol Genet, 2009,18(8):1464-1470. DOI: 10.1093/hmg/ddp057.
[13]MCMANUS M M, WEISS K R, HUGHES D P. Understanding the role of Notch in osteosarcoma[J]. Adv Exp Med Biol, 2014,804:67-92. DOI: 10.1007/978-3-319-04843-7_4.
[14]LI C,GUO D, TANG B, et al. Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression[J]. Neoplasma,2016,63(5):734-742. DOI: 10.4149/neo_2016_510.
[15]WANG L, JIN F, QIN A, et al.Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family[J]. Mol Cancer, 2014,13:139. DOI: 10.1186/1476-4598-13-139.
[16]ZHANG H,LIU L, LIU C, et al. Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma[J]. Oncotarget,2017,8(21):34362-34373. DOI: 10.18632/oncotarget.16156.
[17]YAO J,QIAN C.Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway[J]. Med Oncol, 2010,27(3):1017-1022.DOI: 10.1007/s12032-009-9326-5.
[18]LIU Z, YUN R, YU X, et al. Overexpression of Notch3 and pS6 is associated with poor prognosis in human ovarian epithelial cancer[J]. Mediators Inflamm,2016,2016:5953498. DOI: 10.1155/2016/5953498.

相似文献/References:

[1]蒋平,关伟,戴楠,等.DNA损伤修复基因以及TS、β-tubulinⅢ在骨肉瘤中的表达及其与临床病理的关系[J].第三军医大学学报,2013,35(01):61.
 Jiang Ping,Guan Wei,Dai Nan,et al.Expression of DNA damage repair genes, thymidylate synthase and β-tubulin Ⅲ in human osteosarcoma tissues and its relationship with clinical pathology of osteosarcoma[J].J Third Mil Med Univ,2013,35(07):61.
[2]温磊,孟刚,李懿,等.人骨肉瘤抗失巢凋亡细胞的生物学特性研究[J].第三军医大学学报,2008,30(10):942.
 WEN Lei,MENG Gang,LI Yi,et al.Biological characteristics of anoikis-resistant cells from human osteosarcoma cell line hFOB1.19[J].J Third Mil Med Univ,2008,30(07):942.
[3]李懿,孟刚,郭乔楠.P53和P63蛋白在人骨肉瘤组织及恶性转化细胞株中的表达变化及意义[J].第三军医大学学报,2006,28(08):763.
[4]仲召阳,王东,李增鹏,等.骨肉瘤中APE1的表达及其与血管生成的关系[J].第三军医大学学报,2005,27(10):1045.
[5]卫佳,李星星,陈英华,等.β-catenin降低外源性hS100A6对骨肉瘤细胞的抑制作用[J].第三军医大学学报,2010,32(16):1703.
 Wei Jia,Li Xingxing,Chen Yinghua,et al.β-catenin decreases hS100A6-induced inhibition in osteosarcoma cell lines MG63 and U2OS[J].J Third Mil Med Univ,2010,32(07):1703.
[6]王东,仲召阳,李增鹏,等.骨肉瘤中ephrinB2/EphB4的表达及其与血管生成的关系[J].第三军医大学学报,2004,26(22):0.[doi:10.16016/j.1000-5404.2004.22.024 ]
 WANG Dong,ZHONG Zhao-yang,LI Zeng-peng,et al.[J].J Third Mil Med Univ,2004,26(07):0.[doi:10.16016/j.1000-5404.2004.22.024 ]
[7]何畔,梁珊.RNAi抑制XIAP基因诱导MG63细胞凋亡、化疗增敏及其分子机制[J].第三军医大学学报,2010,32(12):1312.
 He Pan,Liang Shan.RNAi silencing of XIAP gene induces apoptosis and susceptibility to chemotherapy of osteosarcoma cell line MG63[J].J Third Mil Med Univ,2010,32(07):1312.
[8]曾静,温磊,黄玉胜,等.神经营养因子酪氨酸激酶受体B对人永生化成骨细胞hFOB1.19恶性转化细胞体外侵袭力的影响[J].第三军医大学学报,2010,32(09):938.
 Zeng Jing,Wen Lei,Huang Yusheng,et al.Effect of neurotrophic tyrosine kinase receptor B on in vitro invasiveness of malignant transformed hFOB1.19 cells[J].J Third Mil Med Univ,2010,32(07):938.
[9]洪思琦,毕杨,郭振华,等.携带siANGPTL4重组腺病毒的构建及其对MG63增殖的抑制作用[J].第三军医大学学报,2011,33(01):28.
 Hong Siqi,Bi Yang,Guo Zhenhua,et al.Construction of recombinant adenovirus with siANGPTL4 gene and its inhibitive effect on MG63 cell proliferation[J].J Third Mil Med Univ,2011,33(07):28.
[10]周斌,李宏维,史继德,等.PNKP沉默对骨肉瘤放疗的增敏作用[J].第三军医大学学报,2016,38(04):390.
 Zhou Bin,Li Hongwei,Shi Jide,et al.PNKP silencing increases radiosensitivity of osteosarcoma cells in vitro[J].J Third Mil Med Univ,2016,38(07):390.

更新日期/Last Update: 2018-04-09